510(k) K100103
K100103 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "SPECIALTY ASSAYED CONTROL-2". The FDA issued a decision of Substantially Equivalent on December 15, 2010. The device falls under product code GGC (Control, Plasma, Abnormal), a Class II device regulated under 21 CFR 864.5425. Helena Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 15, 2010
- Date Received
- January 13, 2010
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Control, Plasma, Abnormal
- Device Class
- Class II
- Regulation Number
- 864.5425
- Review Panel
- HE
- Submission Type